Otsuka Pays Price As AVP-786 Dropped For Alzheimer's Agitation

Follows Setbacks In Other Uses

Otsuka has already recorded JPY105.5bn loss from AVP-786's P3 fail in the previous year.
Otsuka already booked JPY105.5bn loss in 2023 from AVP-786 failures • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from R&D

More from Scrip